Biden and his advisers defended their decision to authorize boosters for the Pfizer-BioNtech vaccine for some Americans on Friday, saying they let science lead the way
President Joe Biden and his advisers defended their decision to authorize boosters of a third dose of the Pfizer-BioNtech vaccine for some Americans on Friday, saying they let science lead the way.
Despite the announcement, there are lingering questions about the data used to inform the administration’s policy on boosters, including whether there is enough to show the extent to which and the length that boosters can protect against hospitalization and whether the U.S. should worry about any breakthrough infection in the coming months. It is also unclear when exactly individuals working in high risk settings or with underlying health conditions will be able to receive their third shot.
“There are many people who don't get sick enough to go to the hospital who have a waning immunity against symptomatic or moderately symptomatic disease,” he added. “So we've got to be careful that we don't so neatly break it up into if you don't get into the hospital, all as well.” She also rejected the notion that she overruled the advisory panel. "This was a scientific close call," Walensky said.
Walensky's decision early Friday means the federal government will once again need to kick-start a delivery and shipment operation to get booster shots to retail pharmacies and other health care facilities for distribution. The administration will draw on an existing infrastructure first concocted by former President Donald Trump’s Operation Warp Speed which allowed for the delivery of doses to a wide range of settings, including public health departments across the country.
But the FDA does not have final word over how vaccines are used; the CDC is charged with refining which people should get a shot and when. That agency's advisory panel — the Advisory Committee on Immunization Practices — ruled Thursday to limit the distribution of the booster shots to people aged 65 and older and nursing home residents, along with people 18 to 64 with health conditions that increase their risk of severe Covid-19.
Walensky also said that concerns about the disproportionate harm Covid-19 has had on communities of color and the poor also factored into her actions. "Dr. Walensky made a good judgment and showed good leadership in making that decision," Fauci told POLITICO. "I totally agree and support that decision she made."
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Biden says unvaccinated Americans are 'costing all of us' as he presses Covid vaccine mandatesTom Lee, managing partner and the head of research at Fundstrat Global Advisors, joins Mike Santoli, CNBC's senior markets commentator, to discuss how to play the markets in the next phase of the Covid-19 pandemic.\n
Consulte Mais informação »
Biden says COVID-19 boosters will be freeBooster shots to bolster immunity against the coronavirus would be free and accessible, U.S. President Joe Biden said on Friday, one day after federal health agencies backed a booster rollout, and he pledged to get his own shot as soon as possible.
Consulte Mais informação »
Biden hails booster shots as next level in pandemic protectionThe morning after health officials approved the first round of booster shots to prevent coronavirus infections, President Biden said a third dose of the vaccine will provide the “highest level of protection to date.”
Consulte Mais informação »
For asylum advocates, border expulsions strain faith in BidenConfused and tired-looking toddlers clung to their parents at Port-au-Prince airport in Haiti on Tuesday, among the 360 family members rapidly expelled from the U.S. over the past three days.
Consulte Mais informação »
Joe Biden Seeks To Unite Democrats In Do-Or-Die Moment For His AgendaThe president held a series of meetings with lawmakers on Wednesday in an attempt to quell the warring progressive and moderate factions in his party.
Consulte Mais informação »